The Food and Drug Administration has approved Jornay PM (extended-release methylphenidate capsules) ...

Welcome to New York City! APA’s 2018 Annual Meeting began in New York today. From now through May 9,...

Stimulants are a preferred option for treating attention-deficit/hyperactivity disorder (ADHD), but ...

Although some patients who screen positive for attention-deficit/hyperactivity disorder (ADHD) in ad...

Adolescents with more severe symptoms of attention-deficit/hyperactivity disorder (ADHD)—particularl...

People with attention-deficit/hyperactivity disorder (ADHD) are known to be at a higher risk of car ...